# Dave Stevenson

> Dave Stevenson is a Series A investor at Merck Global Health Innovation Fund backing Health Care. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Merck Global Health Innovation Fund](https://shizune.co/investors/profile/merck-global-health-innovation-fund)
- Location: Philadelphia, United States
- Total investments: 2
- Last investment: May 2020
- Lead investor: 50%
- Last updated: Aug 2026

Dave Stevenson is a Series A investor at Merck Global Health Innovation Fund in Philadelphia focused on Health Care and Pharmaceutical. Dave Stevenson is and investment principle responsible for identifying investment opportunities in emerging healthcare solutions and services.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 50% |
| Pharmaceutical | 1 | 50% |
| Information Services | 1 | 50% |
| Information Technology | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 50% |
| Series B | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Ayogo Health | Ayogo is a global leader in the application of behavioral psychology and social gaming to improve health outcomes for patients. Healthier patients improve financial outcomes. Insurers, healthcare providers, ACOs and pharmaceutical companies are Ayogo’s clients. All of our projects begin with meaningful collaboration with patients, end-users andclients. Our corporate culture fosters excellence and thoughtful creation. We maintain the open culture of a startup at our studio in Vancouver’s Centre for Digital Media where our software engineers, user-experience designers, artists and other experts in patient engagement work together. | $7.5M | Series B | May 01, 2020 |  |
| Ayogo Health | Ayogo is a global leader in the application of behavioral psychology and social gaming to improve health outcomes for patients. Healthier patients improve financial outcomes. Insurers, healthcare providers, ACOs and pharmaceutical companies are Ayogo’s clients. All of our projects begin with meaningful collaboration with patients, end-users andclients. Our corporate culture fosters excellence and thoughtful creation. We maintain the open culture of a startup at our studio in Vancouver’s Centre for Digital Media where our software engineers, user-experience designers, artists and other experts in patient engagement work together. |  | Series A | Apr 07, 2015 |  |

2 of 2 investments shown.

## Co-investors
- [7wire Ventures](https://shizune.co/investors/profile/7wire-ventures) — VC Fund, 3 deals together
- [Excel Venture Management](https://shizune.co/investors/profile/excel-venture-management) — VC Fund, 2 deals together
- [Baxter International](https://shizune.co/investors/profile/baxter-international) — VC Fund, 1 deal together
- [MEDTEQ+](https://shizune.co/investors/profile/medteq) — VC Fund, 1 deal together

## About Merck Global Health Innovation Fund

VC Fund · Whitehouse Station, United States

Merck Global Health Innovation Fund (Merck GHI) is evolving corporate healthcare venture capital globally by utilizing their healthcare ecosystem strategy. This investment strategy connects innovative companies with complementary technologies to develop integrated healthcare solutions.Merck GHI has $500M under management and provides growthcapital to emerging healthcare technology companies worldwide while leveraging the vast R&D-based, global resources of Merck.With a vision that data will be the currency in healthcare, GHI invests broadly in digital health. GHI invests in platform companies with proven technologies or business models where Merck's expertise and perspectives can accelerate revenue growth and enhance value creation. Since late 2010, Merck GHI has made over 20 investments in Digital Health companies.

5 contacts available at Merck Global Health Innovation Fund.

| Name | Title | Profile |
| --- | --- | --- |
| Bill Taranto | Founder, President & General Partner | https://shizune.co/investors/profile/william-taranto |
| Bill Taranto | Founder, President & General Partner | https://shizune.co/investors/profile/bill-taranto |
| Dave Stevenson | Managing Director | https://shizune.co/investors/profile/dave-stevenson |
| Joe Volpe | Managing Director and Founding Partner | https://shizune.co/investors/profile/joe-volpe |
| David M. Rubin | Managing Director | https://shizune.co/investors/profile/david-m-rubin |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Dave Stevenson invest in?

Dave Stevenson invests primarily in Health Care, Pharmaceutical and Information Services startups, most often at Series A and Series B stage. Most of the 2 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Dave Stevenson last invest?

The most recent investment recorded for Dave Stevenson closed in May 2020. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co